In the race to have the "first drug specifically for the treatment of lupus", Benlysta seems to be out in front. Benlysta acts to inhibit stimulation of B-cell development, and thus to restore the potential for autoantibody-producing B cells to undergo the normal cell life cycle that has been upset by lupus.

More...